Global Hepatitis C Virus (HCV) Antiviral Market Research Report 2022

Market Analysis and Insights: Global Hepatitis C Virus (HCV) Antiviral Market
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
The global Hepatitis C Virus (HCV) Antiviral market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, HCV Antibody accounting for % of the Hepatitis C Virus (HCV) Antiviral global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Diagnostic Centers segment is altered to an % CAGR throughout this forecast period.
China Hepatitis C Virus (HCV) Antiviral market size is valued at US$ million in 2021, while the North America and Europe Hepatitis C Virus (HCV) Antiviral are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hepatitis C Virus (HCV) Antiviral landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Virus (HCV) Antiviral market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Virus (HCV) Antiviral market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Virus (HCV) Antiviral market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Virus (HCV) Antiviral market.
Global Hepatitis C Virus (HCV) Antiviral Scope and Market Size
Hepatitis C Virus (HCV) Antiviral market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis C Virus (HCV) Antiviral market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
HCV Antibody
HCV Viral Load
HCV Genotyping
Segment by Application
Diagnostic Centers
Hospitals
Home Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals